DEPLOYDatabase

Company

Ekso Bionics

Ekso Bionics is a medical robotics company developing powered exoskeletons for rehabilitation, including the EksoNR for stroke and spinal cord injury patients,…

Track Ekso BionicsGet notified of verified changes
Founded
2005
HQ
Richmond, California, USA
Status
public (NASDAQ: EKSO)

Models

2

Overview

Ekso Bionics is a medical robotics company developing powered exoskeletons for rehabilitation, including the EksoNR for stroke and spinal cord injury patients, and the Ekso GT for industrial worker assistance. (NASDAQ: EKSO)

Verified record

Verified deployments
None on file
Active incidents
2 incidents on file

DEPLOY Intelligence

Market intelligence for physical AI

Analyst-grade signals, competitive tracking, and investment context across the global physical AI landscape. Launching 2026.

Key facts

Robot

Powered medical exoskeletons for lower-limb gait rehabilitation

History

Founded in 2005 as Berkeley ExoWorks

Acquisition

Acquired the Indego product line from Parker Hannifin in early 2023

CEO

Jack Peurach

Listed on

NASDAQ CM: EKSO

Product

EksoNR powered exoskeleton (FDA cleared for SCI and ABI rehab)

Data & sources

Web sources

2

2 sources backing this record.View all →

Explainers

Plain-language answers to the questions people ask about Ekso Bionics, from DEPLOY’s explainer library. Each is written in the language of the question and cross-checked against this registry.

  • What is an exoskeleton robot and how does it work?

    An exoskeleton is a powered wearable robotic device worn by a human that assists or amplifies the wearer's movement. Exoskeletons are not autonomous robots: the wearer's intent drives every action. The category divides between medical exoskeletons (FDA-cleared for rehabilitation and personal mobility) and industrial exoskeletons (worn by workers to reduce fatigue and injury risk).

  • What is Ekso Bionics and what exoskeletons does it make?

    Ekso Bionics is a US medical and industrial exoskeleton manufacturer founded in 2005 (originally Berkeley Bionics) and publicly traded on NASDAQ (EKSO). The EksoNR is FDA-cleared for rehabilitation of stroke and spinal cord injury patients. EksoVest and EksoWorx target industrial workers for overhead and lifting tasks.

Founders (2)

Former / Previously (2)

Safety record

2 incidents on record (1 moderate, 1 minor). Most recent: Apr 2023.

moderate
1
minor
1

Most recent: Apr 2023

Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.

Full safety record: incidents, sourcing, and exposure data →

Incidents affecting Ekso Bionics (2)

Includes incidents linked directly to this company, to its models, or to deployments of its models or under its operation. Retracted incidents are excluded from this view but remain reachable at their canonical URLs.

Operator customers (1)

Peer companies